Literature DB >> 10651658

Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices.

D J Cullen 1, J M Seager, S Holmes, M Doherty, J V Wilson, P Garrud, S Garner, A Maynard, R F Logan, C J Hawkey.   

Abstract

AIM: To investigate the pharmacoepidemiology of NSAID usage in Nottingham general practices.
DESIGN: Questionnaire sent to 1137 consecutive recipients of an NSAID prescription from 21 doctors in six general practices with computerized records. Patient responses were subsequently linked to data held on the practice records.
SETTING: General practices in and around Nottingham, selected to reflect local variations in number of partners, list size, geographical location, deprivation, prescribing burden and prescribing rate.
SUBJECTS: Unselected patients receiving NSAIDs prescribed for all indications. MAIN OUTCOME MEASURES: Indication for treatment, differences in prescribing to different age groups, compliance and overall scheme drug exposure, drug effectiveness and tolerability, possible drug-related adverse events, patients' overall satisfaction with treatment and estimated costs of care.
RESULTS: NSAIDs were used for a wide range of conditions and only a small number of patients had rheumatoid arthritis. The main drugs used were ibuprofen, diclofenac and naproxen. Patients making short-term use of NSAIDs had low compliance if they experienced adverse drug effects, whilst conversely in long-term users, those with high compliance reported more adverse drug effects. Calculated compliance did not vary with age although older patients (over 65 years) claimed in their questionnaires to be more compliant than younger patients. Half the patients reported good or complete symptom relief. Half of those questions (and two thirds of those with good or complete symptom relief) rated their NSAID as the best treatment they had received for their current condition. The frequency of gastrointestinal adverse events was higher in the young and the old, which correlated with the use of anti-ulcer drugs, and increased with the total number of medications used.
CONCLUSIONS: NSAIDs are used for a wide-range of conditions. They give symptom relief to, and are perceived as effective by, most patients taking them.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10651658     DOI: 10.1046/j.1365-2036.2000.00700.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  9 in total

1.  Primary prevention of adverse gastroduodenal effects from short-term use of non-steroidal anti-inflammatory drugs by omeprazole 20 mg in healthy subjects: a randomized, double-blind, placebo-controlled study.

Authors:  Jay C Desai; Shefali M Sanyal; Tyralee Goo; Ariel A Benson; Carol A Bodian; Kenneth M Miller; Lawrence B Cohen; James Aisenberg
Journal:  Dig Dis Sci       Date:  2008-01-26       Impact factor: 3.199

Review 2.  NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options.

Authors:  Jørgen Naesdal; Kurt Brown
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Esomeprazole for the management of upper gastrointestinal symptoms in patients who require NSAIDs: a review of the NASA and SPACE double-blind, placebo-controlled studies.

Authors:  Christopher J Hawkey; Lars-Erik Svedberg; Jørgen Naesdal; Claire Byrne
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 4.  A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity.

Authors:  Philip G Conaghan
Journal:  Rheumatol Int       Date:  2011-12-23       Impact factor: 2.631

5.  Analgesic Medicine Utilization in Older People in New Zealand from 2005 to 2013.

Authors:  Prasad S Nishtala; Sekbong Oh; Daniel Kim; Natalie Chun; Siti Fatimah Binti Kamis; Kuan-Cia Kiu
Journal:  Drugs Real World Outcomes       Date:  2015-06

Review 6.  Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?

Authors:  N D Yeomans; L-E Svedberg; J Naesdal
Journal:  Int J Clin Pract       Date:  2006-11       Impact factor: 2.503

7.  Medication use by persons with chronic fatigue syndrome: results of a randomized telephone survey in Wichita, Kansas.

Authors:  James F Jones; Rosane Nisenbaum; William C Reeves
Journal:  Health Qual Life Outcomes       Date:  2003-12-02       Impact factor: 3.186

8.  Encouraging physician appropriate prescribing of non-steroidal anti-inflammatory therapies: protocol of a randomized controlled trial [ISRCTN43532635].

Authors:  Malcolm Doupe; Alan Katz; Brent Kvern; Lori-Jean Manness; Colleen Metge; Glen T D Thomson; Laura Morrison; Kat Rother
Journal:  BMC Health Serv Res       Date:  2004-08-24       Impact factor: 2.655

Review 9.  Risk of stroke associated with nonsteroidal anti-inflammatory drugs.

Authors:  Ki Park; Anthony A Bavry
Journal:  Vasc Health Risk Manag       Date:  2014-01-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.